When: Confirmed close above 50 SMA at $186 on volume ≥7M shares

Then: Full deployment to 1.0-1.05x (high-conviction trend reversal trigger)

HOLD at 60-80% sizing with $140 stop; do not chase aggressive 90%+ positioning

• 12.9x forward P/E with sub-one PEG and 87% gross margins represents quality but not current timing
• Multiple resistance levels at $164, $168, $176, $181 (200 SMA), and $186 (50 SMA) create hostile path to upside
• 10-year rates at 2002 highs and 200 bps FCF yield spread do not protect against further multiple compression
• 37% EPS growth embedded in forward P/E requires simultaneous execution across bookings growth, take rates, buybacks, and FX
• Stock below 10 EMA ($160.41), 50 SMA, and 200 SMA with all averages in bearish order and death cross intact
• Oct 8 bounce of 2.6% on 7.75M shares volume represents short covering, not conviction buying
• 60-80% sizing with $20 stop risks $12/share; 90%+ sizing risks $20/share for 4-5% marginal upside
• FCF yield spread works for utilities, not 1.13 beta consumer cyclicals with 30%+ peak-to-trough drawdowns
• Waiting for confirmed $186 breakout preserves capital and allows adding on flush to $140-150
• Professional risk management separates long-term conviction from short-term position sizing decisions

→ vs aggressive: The 16% upside to 50 SMA is not asymmetric when stock must clear 5 resistance levels ($164, $168, $176, $181, $186) and has not reclaimed the 10 EMA at $160.41

→ vs aggressive: Rates being 'priced in' does not prevent further yield increases; 12.9x multiple faces compression risk if 10-year makes fresh 2002 highs

→ vs aggressive: Q3 is a binary catalyst, not directional; 37% embedded EPS growth requires flawless execution and cannot be treated as confident base case

→ vs aggressive: 80-100% sizing increases dollar risk by 67% (from $12 to $20 per share unit) for marginal upside gain; fails risk-reward stress test

→ vs aggressive: 200 bps FCF yield spread does not apply to 1.13 beta cyclicals with 30%+ drawdowns; properly risk-adjusted BKNG is fairly valued to modestly cheap, not structurally mispriced

→ vs aggressive: 90% sizing ahead of binary catalyst leaves no dry powder to add on confirmation or capitulation flush to $140-150

HOLD at $160 reference price with 70-75% sizing; $140 stop; flexible add triggers at $176 (5M volume) and $150-155 (positive volume divergence); $186 remains full-deployment trigger; reassess sizing after Q3 earnings

• 12.9x forward P/E with 0.86 PEG is attractive on fundamentals but 200 bps FCF-to-yield spread over 10-year does not make BKNG a bond substitute given 30-plus percent peak-to-trough drawdown and 1.13 beta
• Rates are largely priced in but residual tail risk of further yield leg higher has not been priced out; absence of additional bearish catalysts ≠ absence of bearish risk
• Q3 is binary catalyst with ATR compressed at 5.72 versus August peak of 7.74, indicating coiled market that historically produces outsized moves in either direction
• Q2 revenue growth 8.2% with 11% operating income growth and buybacks running at over 6% of market cap in first half validate momentum thesis
• Q2 2026 FX loss of $195M versus $961M FX gain in Q2 2025 represents $1.16B year-on-year swing in net income from FX; known headwind already partially discounted
• Conservative analyst's resistance sequence ($164, $168, $176, $181, $186 to 50 SMA) is mechanically misleading as moving averages decline with price in an 8-week falling trend
• Conservative analyst underweights Q2 trajectory evidence biasing toward Q3 beat in binary framing
• 60-80% sizing plan creates 'differently timed risk' rather than lower risk; full deployment at $186 reclaim means systematically buying higher as position grows
• $140 stop is structurally meaningful (May 2026 low); tightening to $150 creates high probability of being wicked out given ATR of 5.72
• Macro is hostile in absolute terms but not getting worse on marginal basis given Fed signaling patience; 10-year at 2002 highs
• Post-Q3 volatility regime changes fundamentally; plan should reassess rather than commit to frozen framework through binary catalyst

→ vs aggressive: Bond substitute framing (200 bps FCF yield spread) ignores 30-plus percent peak-to-trough drawdown and 1.13 beta; earnings stream is not a bond coupon and equity risk premium is rightfully being demanded

→ vs aggressive: Rates being 'largely priced in' conflates market digesting current conditions with market being unable to get more bearish; residual tail risk of yield leg higher remains unpriced for a name at low end of historical multiple range

→ vs conservative: 'Gauntlet of resistance' framing is mechanically misleading; moving averages move down alongside price in 8-week decline, and early reversals often clear closest levels on first sentiment shift rather than sequentially

→ vs conservative: Q3 being binary is correct but framing understates bull case given Q2 momentum validation (8.2% revenue, 11% operating income growth) and buyback support; embedded 37% growth assumption may prove conservative if Q2 trajectory continues

→ vs conservative: 60-80% sizing defended as risk-managed actually creates differently timed risk; 16% upside to breakout with 60% size means foregone alpha, and tightening stop to $150 risks being stopped out by routine volatility given ATR of 5.72

→ vs conservative: $186 reclaim as only add trigger is 'conservative to a fault' requiring 16% move before adding means systematically buying higher as position grows